What is Liquidia Technologies, Inc. (LQDA)?
Liquidia Technologies, Inc. is a pharmaceutical company specializing in the development and commercialization of innovative therapies based on its proprietary PRINT (Particle Replication In Non-wetting Templates) technology platform. The company focuses on creating treatments for rare diseases and conditions with significant unmet medical needs. Liquidia's PRINT technology enables precise control over particle size, shape, and composition, which can enhance drug delivery and efficacy. The company's pipeline includes product candidates targeting pulmonary arterial hypertension and other serious health conditions. Liquidia collaborates with various partners and institutions to advance its research and development efforts. The company operates within the biotechnology and pharmaceutical sectors, contributing to advancements in drug formulation and delivery methods. Its activities encompass clinical development, regulatory interactions, and manufacturing processes aimed at bringing novel therapies to patients. Liquidia Technologies is headquartered in the United States and participates in the broader effort to address complex medical challenges through innovative science.
Liquidia Technologies, Inc. Stock Price Today: Live Overview
The price today is shaped by active trading movements, as Liquidia Technologies, Inc. stands at $36.70. Its session range lies between $35.28 and $36.75 with a corresponding daily change of -0.5463%.
FAQ: Liquidia Technologies, Inc. (LQDA)
What is the current price of LQDA stock?
Liquidia Technologies, Inc.'s last price is $36.70.
Does LQDA pay dividends?
Liquidia Technologies, Inc. does not pay dividends.
Does LQDA have a formal corporate presence or regional headquarters in the UAE?
Liquidia Technologies, Inc. has no official presence in the UAE and operates through partners.
What is LQDA best known for?
The company is most famous for its development of inhaled and injectable therapies.
What assets are typically shown together with LQDA?
Commonly shown alongside LQDA: Amphastar Pharmaceuticals Inc, Emergent BioSolutions, DBV Technologies
Latest shares articles



